Publications by authors named "E I Rigopoulou"
Autoimmune hepatitis (AIH) is a rare liver disease, of unknown origin, characterized by considerable heterogeneity. AIH can affect both sexes, of all ages, ethnicities and races. The revised Clinical Practice Guidelines (CPGs) of the Hellenic Association for the Study of the Liver aim to provide updated guidance to clinicians.
View Article and Find Full Text PDFThe night eating syndrome (NES) is characterized by excessive food intake during the evening and night hours, with 25% of the daily intake being consumed post-dinner, paired with ep-isodes of nocturnal food intake, at a frequency of more than twice weekly. The NES has been associated with a misaligned circadian rhythm related to a delay in overall food intake, increased energy and fat consumption. The present cross-sectional study aimed to assess NES in a Greek population and evaluate possible links between NES and chronotype.
View Article and Find Full Text PDFArticle Synopsis
- The study investigates the impact of primary sclerosing cholangitis (PSC) on liver-related symptoms during pregnancy, highlighting a gap in pre-conception risk assessment and management guidelines.
- A total of 450 patients were analyzed, revealing that 28.9% experienced worsened liver symptoms during pregnancy after PSC diagnosis, correlating with a decreased transplant-free survival rate.
- It was also found that some women exhibited liver-related symptoms before PSC diagnosis, suggesting that pregnancy might trigger or uncover early signs of the disease.
FibroMeter scores are predictive noninvasive markers of advanced and significant liver fibrosis in patients with chronic viral hepatitis or metabolic dysfunction-associated steatotic liver disease.
Ann Gastroenterol
November 2023
Background: FibroMeter and FibroMeter vibration-controlled transient elastography (FibroMeter VCTE) were assessed in a Greek cohort of patients with chronic viral hepatitis (CVH) B and C or metabolic dysfunction-associated steatotic liver disease (MASLD) to evaluate their accuracy in predicting advanced liver fibrosis against other well-validated noninvasive markers.
Methods: Group 1: n=83 CVH and group 2: n=38 MASLD patients underwent liver biopsy and transient elastography (TE) on the same day as sera collection. FibroMeter scores APRI and FIB-4 were calculated in all 121 patients, while MASLD fibrosis score (MFS) was also calculated in group 2.